BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15817895)

  • 1. Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRP-independent process.
    Benchenane K; Berezowski V; Fernández-Monreal M; Brillault J; Valable S; Dehouck MP; Cecchelli R; Vivien D; Touzani O; Ali C
    Stroke; 2005 May; 36(5):1065-70. PubMed ID: 15817895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.
    Yepes M; Sandkvist M; Moore EG; Bugge TH; Strickland DK; Lawrence DA
    J Clin Invest; 2003 Nov; 112(10):1533-40. PubMed ID: 14617754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis.
    Benchenane K; Berezowski V; Ali C; Fernández-Monreal M; López-Atalaya JP; Brillault J; Chuquet J; Nouvelot A; MacKenzie ET; Bu G; Cecchelli R; Touzani O; Vivien D
    Circulation; 2005 May; 111(17):2241-9. PubMed ID: 15851587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.
    Zhang X; Polavarapu R; She H; Mao Z; Yepes M
    Am J Pathol; 2007 Oct; 171(4):1281-90. PubMed ID: 17717150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Desmodus rotundus salivary plasminogen activator crosses the blood-brain barrier through a low-density lipoprotein receptor-related protein-dependent mechanism without exerting neurotoxic effects.
    López-Atalaya JP; Roussel BD; Ali C; Maubert E; Petersen KU; Berezowski V; Cecchelli R; Orset C; Vivien D
    Stroke; 2007 Mar; 38(3):1036-43. PubMed ID: 17325305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
    Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
    Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
    Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
    J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
    Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
    Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator extravasated through the cerebral vessels: evaluation using a rat thromboembolic stroke model.
    Harada T; Kano T; Katayama Y; Matsuzaki T; Tejima E; Koshinaga M
    Thromb Haemost; 2005 Oct; 94(4):791-6. PubMed ID: 16270632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
    Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
    Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. tPA in the central nervous system: relations between tPA and cell surface LRPs.
    Ortolano S; Spuch C
    Recent Pat Endocr Metab Immune Drug Discov; 2013 Jan; 7(1):65-76. PubMed ID: 23231415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
    Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
    Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
    Wang X; Lee SR; Arai K; Lee SR; Tsuji K; Rebeck GW; Lo EH
    Nat Med; 2003 Oct; 9(10):1313-7. PubMed ID: 12960961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
    Liu H; Wang Y; Xiao Y; Hua Z; Cheng J; Jia J
    Transl Stroke Res; 2016 Jun; 7(3):209-19. PubMed ID: 27018013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions.
    Freeman R; Niego B; Croucher DR; Pedersen LO; Medcalf RL
    Brain Res; 2014 May; 1565():63-73. PubMed ID: 24675027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperthermia masks the neuroprotective effects of tissue plaminogen activator.
    Noor R; Wang CX; Shuaib A
    Stroke; 2005 Mar; 36(3):665-9. PubMed ID: 15705940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
    Zhang C; An J; Haile WB; Echeverry R; Strickland DK; Yepes M
    J Cereb Blood Flow Metab; 2009 Dec; 29(12):1946-54. PubMed ID: 19672275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
    Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC
    Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.